Melatonin dispensing among New Zealand children aged 0-18 years with autism: a nationwide cross-sectional study.

摘要: Abstract Objective/background Sleep problems in children on the autism spectrum are prevalent and persistent. Such result of a combination biopsychosocial factors, including abnormal melatonin secretion. Exogenous is an empirically supported popular treatment for sleep problems. However, we know little about rates dispensing associated variables. This study investigated sociodemographic child characteristics with its use New Zealand. Methods nationwide cross-sectional used linked administrative health data obtained via Integrated Data Infrastructure (IDI). were 11,202, 0–18 year old spectrum. Descriptive data, adjusted unadjusted risk ratios, calculated characteristics. Results Melatonin accessed by almost one quarter Zealand, higher observed among females those aged between 5 11 years, European ethnicity, presenting co-occurring mental conditions. Conclusions Findings largely consistent research investigating both disturbances psychotropic drug High use, age- sex-related differences complexity presence conditions necessitates development practice guidelines dispensing. Further investigation into duration interaction characteristics, conditions, variables warranted.